DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1.
Zhang J, Li Y, Guo L, Cao R, Zhao P, Jiang W, Ma Q, Yi H, Li Z, Jiang J, Wu J, Wang Y, Si S.
Zhang J, et al. Among authors: ma q.
Cancer Biol Ther. 2009 Dec;8(24):2374-83. doi: 10.4161/cbt.8.24.10182. Epub 2009 Dec 27.
Cancer Biol Ther. 2009.
PMID: 19855194
Free article.